Seguir
Farhan S Cyprian
Farhan S Cyprian
Qatar Univerisity
Dirección de correo verificada de qu.edu.qa
Título
Citado por
Citado por
Año
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms
MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ...
Viruses 11 (8), 762, 2019
4272019
Immunomodulatory effects of vitamin D in pregnancy and beyond
F Cyprian, E Lefkou, K Varoudi, G Girardi
Frontiers in immunology 10, 2739, 2019
1592019
Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: a new clinical paradigm in the treatment of triple-negative breast cancer
FS Cyprian, S Akhtar, Z Gatalica, S Vranic
Bosnian Journal of Basic Medical Sciences 19 (3), 227, 2019
1162019
iNKT cell development is orchestrated by different branches of TGF-β signaling
JM Doisne, L Bartholin, KP Yan, CN Garcia, N Duarte, JB Le Luduec, ...
Journal of Experimental Medicine 206 (6), 1365-1378, 2009
1132009
PD-L1 status in breast cancer: current view and perspectives
S Vranic, FS Cyprian, Z Gatalica, J Palazzo
Seminars in cancer biology 72, 146-154, 2021
962021
Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells
RA El-Awady, MH Semreen, MM Saber-Ayad, F Cyprian, V Menon, ...
DNA repair 37, 1-11, 2016
732016
Epstein–Barr virus and human papillomaviruses interactions and their roles in the initiation of epithelial–mesenchymal transition and cancer progression
FS Cyprian, HF Al-Farsi, S Vranic, S Akhtar, AE Al Moustafa
Frontiers in Oncology 8, 111, 2018
602018
Epstein–Barr virus in gliomas: cause, association, or artifact?
S Akhtar, S Vranic, FS Cyprian, AE Al Moustafa
Frontiers in oncology 8, 123, 2018
552018
The role of epstein–barr virus in cervical cancer: a brief update
S Vranic, FS Cyprian, S Akhtar, AE Al Moustafa
Frontiers in oncology 8, 113, 2018
532018
Generation of mice with conditionally activated transforming growth factor beta signaling through the TβRI/ALK5 receptor
L Bartholin, FS Cyprian, D Vincent, CN Garcia, S Martel, B Horvat, ...
genesis 46 (12), 724-731, 2008
502008
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
F Cyprian, MU Sohail, I Abdelhafez, S Salman, Z Attique, L Kamareddine, ...
International Journal of Infectious Diseases 105, 540-550, 2021
402021
Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer
D Elkhalifa, AB Siddique, M Qusa, FS Cyprian, K El Sayed, F Alali, ...
European Journal of Medicinal Chemistry 187, 111954, 2020
382020
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery–a comprehensive systematic review and meta-analysis
T Chivese, JT Matizanadzo, OAH Musa, G Hindy, L Furuya-Kanamori, ...
Pathogens and global health 116 (5), 269-281, 2022
362022
Cytokine responses in campylobacteriosis: Linking pathogenesis to immunity
NA Al-Banna, F Cyprian, MJ Albert
Cytokine & growth factor reviews 41, 75-87, 2018
322018
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019; 11 (8): 762
MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ...
282019
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
V Sasidharan Nair, R Saleh, SM Toor, FS Cyprian, E Elkord
Cancer immunology, immunotherapy 70, 2103-2121, 2021
272021
SnoRNAs and miRNAs networks underlying COVID-19 disease severity
A Parray, FA Mir, A Doudin, A Iskandarani, IMM Danjuma, RAT Kuni, ...
Vaccines 9 (10), 1056, 2021
222021
Development of oral cancer
AE Al Moustafa
Risk Factors and Prevention Strategies. Doha 10, 978-3, 2017
202017
Complement C5a and clinical markers as predictors of COVID-19 disease severity and mortality in a multi-ethnic population
FS Cyprian, M Suleman, I Abdelhafez, A Doudin, IM Masud Danjuma, ...
Frontiers in Immunology 12, 707159, 2021
192021
Mycoplasma bovis-induced inhibition of bovine peripheral blood mononuclear cell proliferation is ameliorated after blocking the immune-inhibitory programmed death 1 receptor
M Suleman, FS Cyprian, S Jimbo, T Maina, T Prysliak, C Windeyer, ...
Infection and immunity 86 (3), 10.1128/iai. 00921-17, 2018
192018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20